Table 2.

Infection Timing, With Rows in Chronological Order by Date That First Trial Commenced (With Top Row Earliest).

	Screening Trial Duration (Days)	Time From Trial Start to Full Implant	Time From Trial Start to Infection
Belgium	13	34	53
Belgium	21	N/A	18
Belgium	29	N/A	29
Canada	27	27	52
Belgium	56	N/A	10
Belgium	36	N/A	58
USA*	3	16	66
France	7	N/A	7
Spain	11	12	21

^* Percutaneous electrodes; the rest were surgical leads.